Publication | Closed Access

A conformational restriction approach to the development of dual inhibitors of acetylcholinesterase and serotonin transporter as potential agents for Alzheimer's disease

Alzheimer's DiseaseBiochemistryDual InhibitorsMedicineNeurotransmitterNeuropharmacologyNeurochemical BiomarkersProtein MisfoldingNeuroscienceMolecular SubstratePharmacologyNeurochemistryConformational Restriction ApproachDrug DiscoverySerotonin Transporter